Morbidity and Mortality Weekly Report (MMWR)
This list contains articles published weekly.
- Notes from the Field: Increase in Nontoxigenic Corynebacterium diphtheriae - Washington, 2018-2023on May 2, 2024 at 5:15 pm
- Cigarette Smoking Among Pregnant Women During the Perinatal Period: Prevalence and Health Care Provider Inquiries - Pregnancy Risk Assessment Monitoring System, United States, 2021on May 2, 2024 at 5:00 pm
- Prevalence of Positive Childhood Experiences Among Adults - Behavioral Risk Factor Surveillance System, Four States, 2015-2021on May 2, 2024 at 5:00 pm
- Erratum: Vol. 72, No. 29on May 2, 2024 at 5:00 pm
- Emergency Department Visits for Pedestrians Injured in Motor Vehicle Traffic Crashes - United States, January 2021-December 2023on May 2, 2024 at 5:00 pm
- QuickStats: Percentage of Residential Care Communities That Use Electronic Health Records, by Community Bed Size - United States, 2018, 2020, and 2022on May 2, 2024 at 5:00 pm
- SURVEILLANCE SUMMARIES: Preventable Premature Deaths from the Five Leading Causes of Death in Nonmetropolitan and Metropolitan Counties, United States, 2010-2022on April 30, 2024 at 5:00 pm
- Heat-Related Emergency Department Visits - United States, May-September 2023on April 29, 2024 at 3:06 pm
- Notes from the Field: Group A Streptococcus Bacteremia in Persons Who Inject Drugs - Northern Vermont, January 2020-October 2023on April 29, 2024 at 3:06 pm
- QuickStats: Percentage of Employed Adults Aged ≥18 Years Who Slept 7 Hours per 24-Hour Period, by Sex and Number of Work Hours per Week - United States, 2022on April 25, 2024 at 5:00 pm
- Use of Ebola Vaccines - Worldwide, 2021-2023on April 25, 2024 at 5:00 pm
- SARS-CoV-2 Viral Shedding and Rapid Antigen Test Performance - Respiratory Virus Transmission Network, November 2022-May 2023on April 25, 2024 at 5:00 pm
- Investigation of Presumptive HIV Transmission Associated with Receipt of Platelet-Rich Plasma Microneedling Facials at a Spa Among Former Spa Clients - New Mexico, 2018-2023on April 25, 2024 at 5:00 pm
- Use of an Additional Updated 2023-2024 COVID-19 Vaccine Dose for Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024on April 25, 2024 at 5:00 pm
- Use of the Pfizer Pentavalent Meningococcal Vaccine Among Persons Aged ≥10 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023on April 18, 2024 at 5:00 pm